Hospital-Based Strategies for Combating Resistance

Owens, Jr., Robert C.; Rice, Louis
April 2006
Clinical Infectious Diseases;4/15/2006 Supplement, Vol. 42, pS173
Academic Journal
Selective pressures generated by the indiscriminate use of β-lactam antibiotics have resulted in increased bacterial resistance across all β-lactams classes. In particular, the use of third-generation cephalosporins has been associated with the emergence of extended-spectrum β-lactamase-producing and AmpC β-lactamase-producing Enterobacteriaceae and vancomycin-resistant enterococci. Conversely, β-lactams (e.g., cefepime, piperacillin-tazobactam, and ampicillin-sulbactam) have not demonstrated such strong selective pressures. Chief among institutional strategies to control outbreaks of multidrug-resistant bacteria are infection-control measures and interventional programs designed to minimize the use of antimicrobial agents that are associated with strong relationships between use and resistance. Successful programs include antimicrobial stewardship programs (prospective audit and feedback), formulary interventions (therapeutic substitutions), formulary restrictions, and vigilant infection control. Fourth-generation cephalosporins, such as cefepime, have proven to be useful substitutes for third-generation cephalosporins, as a part of an overall strategy to minimize the selection and impact of antimicrobial-resistant organisms in hospital settings.


Related Articles

  • Enzymes act like a switch, turning antibiotic resistance on and off in enterococci.  // Biomedical Market Newsletter;11/7/2011, Vol. 21, p39 

    The article focuses on antibiotic-resistant enterococci, the most common antibiotic-resistant bacteria that commonly live in intestines that are a serious problem for patients in the hospital. Discoveries on the ways enterococci turn their resistance to cephalosporin antibiotics, medicines that...

  • Kirby-Bauer disc approximation to detect inducible third-generation cephalosporin resistance in Enterobacteriaceae. Xuan Qin; Weissman, Scott J.; Chesnut, Mary Frances; Bei Zhang; Lisong Shen // Annals of Clinical Microbiology & Antimicrobials;2004, Vol. 3, p1 

    Resistance to β-lactam antibiotics in enteric Gram-negative bacilli may be difficult to detect using standard methods of either Kirby-Bauer disc diffusion (KBDD) or broth dilution for minimal inhibitory concentration (MIC). This difficulty is due to genetic differences in resistance...

  • Comparison of double disc and three dimensional methods to screen for ESBL producers in a tertiary care hospital. Menon, T.; Bindu, D.; Kumar, C. P. G.; Nalini, S.; Thirunarayan, M. A. // Indian Journal of Medical Microbiology;Apr2006, Vol. 24 Issue 2, p117 

    Extended spectrum beta lactamases (ESBLs) continue to be a major problem in clinical setups world over, conferring resistance to the expanded spectrum cephalosporins. An attempt was made to study ESBL production among Enterobacteriaceae members from a tertiary care center in Chennai. A total of...

  • Enterococcus: not an innocent bystander in cirrhotic patients with spontaneous bacterial peritonitis. Lee, J.-H.; Yoon, J.-H.; Kim, B. H.; Chung, G. E.; Myung, S. J.; Kim, W.; Kim, Y. J.; Kim, E.-C.; Lee, H.-S. // European Journal of Clinical Microbiology & Infectious Diseases;Jan2009, Vol. 28 Issue 1, p21 

    Clinicians sometimes experience treatment failure in the initial empirical antibiotics treatment using cephalosporins in cirrhotic patients with spontaneous bacterial peritonitis (SBP). Enterococcus, which is intrinsically resistant to cephalosporins, may be one of the causes of treatment...

  • Structural studies of the mechanism for biosensing antibiotics in a fluoresceinlabeled βlactamase. Wai-Ting Wong; Ho-Wah Au; Hong-Kin Yap; Yun-Chung Leung; Kwok-Yin Wong; Yanxiang Zhao // BMC Structural Biology;2011, Vol. 11 Issue 1, p15 

    Background: β-lactamase conjugated with environment-sensitive fluorescein molecule to residue 166 on the ∩-loop near its catalytic site is a highly effective biosensor for β-lactam antibiotics. Yet the molecular mechanism of such fluorescence-based biosensing is not well understood....

  • REDUCED ANTIBIOTIC USE IN LIVESTOCK: How Denmark Tackled Resistance. Levy, Sharon // Environmental Health Perspectives;Jun2014, Vol. 122 Issue 6, pA160 

    The article focuses on the problem of widespread antibiotics use in livestock and efforts of the country of Denmark in tackling this problem. Topics discussed include reforms to antibiotic use for livestock that are reducing the prevalence of resistant bacteria in Denmark, revolutionized...

  • Design and Synthesis of Novel Thioether-linked Carbapenem-Oxazolidinone Hybrids as Potential Antimicrobial Agents. Wang, Jianwei; Juan Huang; Yong Wu; Li Hai; Guangming Wang // Letters in Organic Chemistry;Jul2008, Vol. 5 Issue 5, p336 

    Discovery of novel antimicrobial agents effective against infections caused by drug-resistant pathogens is an important objective in drug research field. In order to find new structural classes of antibiotics, a series of novel thioether-linked carbapenem-oxazolidinone hybrids were synthesized....

  • Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Liss, B.; Vehreschild, J.; Cornely, O.; Hallek, M.; Fätkenheuer, G.; Wisplinghoff, H.; Seifert, H.; Vehreschild, M. // Infection;Dec2012, Vol. 40 Issue 6, p613 

    Background: In patients with haematological or oncological malignancies, we aimed to assess the rate of intestinal colonisation and blood stream infections (BSI) with extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) and vancomycin-resistant enterococci (VRE), mortality and...

  • In the Literature.  // Clinical Infectious Diseases;Oct2014, Vol. 59 Issue 7, piii 

    The author reflects on the article "The impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci" by K. Hayakawa and colleagues. The author mentions that Hayakawa and colleagues in Detroit, Michigan examined...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics